Send me a link:

*Text messaging rates may apply.

 Dow Up0.35% Nasdaq Up0.59%

Elite Pharmaceuticals, Inc. (ELTP)

-OBB
0.35 Down 0.00(0.14%) 2:40PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 1,028   1,693   1,159   722  
Cost of Revenue1,046  995  617  579  
Gross Profit (18) 699   542   143  
Operating Expenses
Research Development1,244  1,291  855  569  
Selling General and Administrative993  518  291  386  
Non Recurring -   -   -   -  
Others129  127  83  163  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,384) (1,237) (687) (976)
Income from Continuing Operations
Total Other Income/Expenses Net(84,539)534  (8,675)1,996  
Earnings Before Interest And Taxes(86,923)(703)(9,362)1,020  
Interest Expense170  358  273  98  
Income Before Tax(87,092)(1,062)(9,635)922  
Income Tax Expense(295) -  2   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(86,798)(1,062)(9,638)922  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (86,798) (1,062) (9,638) 922  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (86,798) (1,062) (9,638) 922  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.